OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell, Lisa M. Coussens
Cancer Cell (2015) Vol. 27, Iss. 4, pp. 462-472
Open Access | Times Cited: 1289

Showing 1-25 of 1289 citing articles:

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo, et al.
Cell (2017) Vol. 168, Iss. 4, pp. 707-723
Open Access | Times Cited: 4381

Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri Moghaddam, Saeed Mohammadian Haftcheshmeh, Hossein Vazini, et al.
Journal of Cellular Physiology (2018) Vol. 233, Iss. 9, pp. 6425-6440
Closed Access | Times Cited: 3678

Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani, Federica Marchesi, Alberto Malesci, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 7, pp. 399-416
Open Access | Times Cited: 3243

The immune contexture in cancer prognosis and treatment
Wolf H. Fridman, Laurence Zitvogel, Catheriné Sautès-Fridman, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 717-734
Closed Access | Times Cited: 1882

Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo, Brian Ruffell
Nature reviews. Immunology (2019) Vol. 19, Iss. 6, pp. 369-382
Open Access | Times Cited: 1841

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang, Baoli Hu, Xin Hu, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 42-56.e6
Open Access | Times Cited: 1634

Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta, Jeffrey W. Pollard
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 887-904
Open Access | Times Cited: 1579

Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale, Gwenola Manic, Lisa M. Coussens, et al.
Cell Metabolism (2019) Vol. 30, Iss. 1, pp. 36-50
Open Access | Times Cited: 1325

Tumor microenvironment as a therapeutic target in cancer
Yi Xiao, Dihua Yu
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107753-107753
Open Access | Times Cited: 1210

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin, Jian‐Xin Xu, Huiyin Lan
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 1161

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1101

Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1076

Therapeutic cancer vaccines
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3401-3412
Open Access | Times Cited: 1036

Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier, Sherine F. Elsawa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6995-6995
Open Access | Times Cited: 1015

PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda, Karen Messer, Natacha Ralainirina, et al.
Nature (2016) Vol. 539, Iss. 7629, pp. 437-442
Open Access | Times Cited: 993

Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 6, pp. 366-381
Open Access | Times Cited: 905

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell, Sean P. Arlauckas, Michael F. Cuccarese, et al.
Nature Biomedical Engineering (2018) Vol. 2, Iss. 8, pp. 578-588
Open Access | Times Cited: 884

Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen, Yucen Song, Wei Du, et al.
Journal of Biomedical Science (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 883

Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip J. Gotwals, Scott B. Cameron, Daniela Cipolletta, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 286-301
Closed Access | Times Cited: 866

Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria, Tiani L. Louis, Judith A. Varner
Trends in Immunology (2019) Vol. 40, Iss. 4, pp. 310-327
Closed Access | Times Cited: 793

Harnessing innate immunity in cancer therapy
Olivier Demaria, Stéphanie Cornen, Marc Daëron, et al.
Nature (2019) Vol. 574, Iss. 7776, pp. 45-56
Closed Access | Times Cited: 751

The Basis of Oncoimmunology
Karolina Palucka, Lisa M. Coussens
Cell (2016) Vol. 164, Iss. 6, pp. 1233-1247
Open Access | Times Cited: 738

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
Elisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 17
Open Access | Times Cited: 735

Tumor microenvironment: Sanctuary of the devil
Lanlan Hui, Ye Chen
Cancer Letters (2015) Vol. 368, Iss. 1, pp. 7-13
Closed Access | Times Cited: 710

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
Yu Zhu, John M. Herndon, Dorothy K. Sojka, et al.
Immunity (2017) Vol. 47, Iss. 2, pp. 323-338.e6
Open Access | Times Cited: 684

Page 1 - Next Page

Scroll to top